               SEQUENCE LISTING

<110> Forschungszentrum Juelich GmbH

<120> VERWENDUNG VON D-ENANTIOMEREN PEPTIDLIGANDEN VON MONOMEREM A-SYNUCLEIN FÜR DIE THERAPIE VERSCHIEDENER SYNUCLEINOPATHIEN

<130> D/FZJDUE-044-PC

<160> 7

<170> BiSSAP 1.3.6

<210> 1
<211> 16
<212> PRT
<213> Artificial Sequence


<220> 
<223> D-Peptide

<400> 1
Lys Met Pro Thr His Glu Thr Tyr Trp Gln Glu His Ile Trp His Ala 
1               5                   10                  15      

    

<210> 2
<211> 16
<212> PRT
<213> Artificial Sequence


<220> 
<223> D-Peptide

<400> 2
Tyr Asp Trp Lys Gln Pro Met Ser Ala Ser Arg Phe Leu Ala Pro Trp 
1               5                   10                  15      



<210> 3
<211> 16
<212> PRT
<213> Artificial Sequence


<220> 
<223> D-Peptide

<400> 3
Ser Ser His Trp Gln Gln Trp Asn Pro Pro Tyr Trp Asn Thr Asp Ser 
1               5                   10                  15      
     

<210> 4
<211> 16
<212> PRT
<213> Artificial Sequence


<220> 
<223> D-Peptide

<400> 4
Tyr Asp Trp Lys Gln Pro Met Ser Ala Ser Arg Phe Leu Ala Pro Trp  
1               5                   10                  15      
Arg 

<210> 5
<211> 21
<212> PRT
<213> Artificial Sequence


<220> 
<223> D-Peptide

<400> 5
Arg Leu Pro Thr His Glu Thr Tyr Trp Gln Glu His Ile Trp His Ala 
1               5                   10                  15      
Arg Arg Arg Arg Arg 
            20      

<210> 6
<211> 21
<212> PRT
<213> Artificial Sequence


<220> 
<223> D-Peptide

<400> 6
Tyr Asp Trp Arg Gln Pro Leu Ser Ala Ser Arg Phe Leu Ala Pro Trp  
1               5                   10                  15      
Arg Arg Arg Arg Arg 
            20      

<210> 7
<211> 21
<212> PRT
<213> Artificial Sequence


<220> 
<223> D-Peptide

<400> 7
Ser Ser His Trp Gln Gln Trp Asn Pro Pro Tyr Trp Asn Thr Asp Ser 
1               5                   10                  15      
Arg Arg Arg Arg Arg 
            20  
        

